| Hester Biosciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524669 |
NSE Symbol : HESTERBIO |
P/E(TTM) : 34.03 |
|
ISIN Demat : INE782E01017 |
Div & Yield% : 0.51 |
EPS(TTM) : 63.10 |
|
Book Value(₹) : 452.79 |
Market Cap(₹Cr) : 1,826.59 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 72.66 | 93.71 | 70.35 | 64.58 | 63.49 | 76.67 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 72.66 | 93.71 | 70.35 | 64.58 | 63.49 | 76.67 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.68 | 11.18 | 1.04 | 1.48 | 0.95 | 1.06 |
| Total Income | 74.34 | 104.89 | 71.39 | 66.05 | 64.44 | 77.73 |
| Total Expenditure | 48.31 | 62.25 | 53.64 | 52.70 | 51.08 | 62.97 |
| PBIDT | 26.03 | 42.64 | 17.75 | 13.36 | 13.36 | 14.76 |
| Interest | 1.36 | 4.09 | 0.90 | 1.27 | 0.91 | 1.25 |
| PBDT | 24.67 | 38.55 | 16.85 | 12.08 | 12.45 | 13.51 |
| Depreciation | 4.92 | 3.68 | 2.21 | 2.20 | 2.16 | 2.03 |
| Tax | 4.56 | 7.72 | 2.42 | 2.48 | 1.84 | 3.67 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.48 | 0.76 | 1.55 | 0.19 | 0.61 | -1.82 |
| Reported Profit After Tax | 14.71 | 26.38 | 10.67 | 7.21 | 7.84 | 9.64 |
| Extra-ordinary Items | 0.00 | 5.29 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 14.71 | 21.09 | 10.67 | 7.21 | 7.84 | 9.64 |
| EPS (Unit Curr.) | 17.29 | 31.01 | 12.54 | 8.48 | 9.21 | 11.33 |
| EPS (Adj) (Unit Curr.) | 17.29 | 31.01 | 12.54 | 8.48 | 9.21 | 11.33 |
| Calculated EPS (Unit Curr.) | 17.29 | 31.01 | 12.54 | 8.47 | 9.21 | 11.33 |
| Calculated EPS (Adj) (Unit Curr.) | 17.29 | 31.01 | 12.54 | 8.47 | 9.21 | 11.33 |
| Calculated EPS (Ann.) (Unit Curr.) | 69.17 | 124.06 | 50.17 | 33.90 | 36.85 | 45.30 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 69.17 | 124.06 | 50.17 | 33.90 | 36.85 | 45.30 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 35.82 | 45.50 | 25.23 | 20.69 | 21.04 | 19.25 |
| PBDTM(%) | 33.95 | 41.14 | 23.95 | 18.71 | 19.61 | 17.62 |
| PATM(%) | 20.24 | 28.15 | 15.17 | 11.16 | 12.35 | 12.57 |
